يعرض 1 - 10 نتائج من 64 نتيجة بحث عن '"Chemotaxis/*drug effects"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Biomechanics and Modeling in Mechanobiology, 20 (4), 1627 - 1644 (2021-08)

    Relation: https://link.springer.com/content/pdf/10.1007/s10237-021-01466-0.pdf; urn:issn:1617-7959; urn:issn:1617-7940

  2. 2
  3. 3

    المساهمون: RS: Carim - B01 Blood proteins & engineering, Biochemie, RS: CARIM - R3.07 - Structure-function analysis of the chemokine interactome for therapeutic targeting and imaging in atherosclerosis

    المصدر: Cardiovascular research, vol. 115, no. 3, pp. 602-613
    Cardiovascular Research
    Cardiovascular Research, Vol. 115, No 3 (2019) pp. 602-613
    Cardiovascular Research, 115(3), 602-613. Oxford University Press

    مصطلحات موضوعية: 0301 basic medicine, Diacylglycerol lipase, Cannabinoid receptor, Myeloid, Physiology, Neutrophils, 2-Arachidonoylglycerol, Monoacylglycerol lipase, Myocardial Infarction, 030204 cardiovascular system & hematology, CANNABINOID RECEPTOR 2, Monocytes, Receptor, Cannabinoid, CB2, chemistry.chemical_compound, 0302 clinical medicine, ACTIVATED ENDOCANNABINOID SYSTEM, Myeloid Cells, Myocardial infarction, JZL184, Mice, Knockout, biology, Ventricular Remodeling, Chemotaxis, GRANULOPOIESIS, Sciences bio-médicales et agricoles, medicine.anatomical_structure, Neutrophil Infiltration, cardiovascular system, Disease Progression, Administration, Intravenous, Female, Inflammation Mediators, Cardiology and Cardiovascular Medicine, Signal Transduction, Cardiac function curve, medicine.medical_specialty, BONE-MARROW, Arachidonic Acids, Glycerides, 03 medical and health sciences, INFLAMMATION, Physiology (medical), Internal medicine, medicine, INJURY, Animals, cardiovascular diseases, Heart Failure, Palmitoylethanolamide, CB2 cannabinoid receptor, business.industry, Myocardium, MATRIX-METALLOPROTEINASE-9, ddc:614.1, PROTAGONISTS, medicine.disease, Fibrosis, Monoacylglycerol Lipases, Mice, Inbred C57BL, Disease Models, Animal, 030104 developmental biology, Endocrinology, chemistry, IMMUNE CELLS, biology.protein, Arachidonic Acids/administration & dosage, Arachidonic Acids/metabolism, Arachidonic Acids/toxicity, Chemotaxis/drug effects, Endocannabinoids/administration & dosage, Endocannabinoids/metabolism, Endocannabinoids/toxicity, Glycerides/administration & dosage, Glycerides/metabolism, Glycerides/toxicity, Heart Failure/chemically induced, Heart Failure/metabolism, Heart Failure/physiopathology, Inflammation Mediators/metabolism, Monoacylglycerol Lipases/metabolism, Myeloid Cells/drug effects, Myeloid Cells/metabolism, Myocardial Infarction/complications, Myocardial Infarction/metabolism, Myocardial Infarction/pathology, Myocardial Infarction/physiopathology, Myocardium/metabolism, Myocardium/pathology, Neutrophil Infiltration/drug effects, Receptor, Cannabinoid, CB2/genetics, Receptor, Cannabinoid, CB2/metabolism, Ventricular Remodeling/drug effects, business, Endocannabinoids

    وصف الملف: application/pdf; 2 full-text file(s): application/pdf

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    المساهمون: Centre méditerranéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie Cellulaire et Moléculaire de l'Obésité et du Diabète (Equipe 7), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Nice Sophia Antipolis (... - 2019) (UNS), Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Laboratoire Tolérance Immunitaire (TIM), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA), Toxines bactériennes dans la relation hôtes-pathogènes, Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR50-Université Côte d'Azur (UCA)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), This study was supported by The European Foundation for the Study of Diabetes (EFSD), INCA (grants 2010-219 and 2010-214) and the 'Fondation ARC.' B. Dirat was supported by INCA grant 2010-219, the Cancerople PACA, and the Région PACA. F. Bost, J.F. Tanti, and A. Mettouchi are investigators of the Centre National de la Recherche Scientifique (CNRS). F. Massa is supported by ITMO-Cancer. This work was supported by the French Government (National Research Agency, ANR) through the 'Investments for the Future' LABEX SIGNALIFE (grant ANR-11-0028-01), The authors thank Anne Doye and Rachel Paul-Bellon for technical assistance, Pr. Mitchell and Dr. Becanovic for The HA–PREX plasmid, Issam Ben-Sahra, Stéphane Ricoult, Jérôme Gilleron, Sophie Giorgetti-Peraldi, and Yannick Le Marchand Brustel for their help and the critical reading of the article. The authors greatly acknowledge Damien Alcor of the C3M (or MicorBio) Cell Imaging Facility., ANR-11-LABX-0028,SIGNALIFE,Réseau d'Innovation sur les Voies de Signalisation en Sciences de la Vie(2011)

    المصدر: Molecular Cancer Therapeutics
    Molecular Cancer Therapeutics, American Association for Cancer Research, 2015, 14 (2), pp.586-596. ⟨10.1158/1535-7163.MCT-14-0102⟩

    مصطلحات موضوعية: Male, rac1 GTP-Binding Protein, Cancer Research, Cytoskeleton organization, [SDV]Life Sciences [q-bio], Cell, MESH: Actin Cytoskeleton/drug effects, [SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC], MESH: rac1 GTP-Binding Protein/metabolism, Prostate cancer, 0302 clinical medicine, MESH: Cell Proliferation/drug effects, Cell Movement, MESH: Actin Cytoskeleton/metabolism, [SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB], Cyclic AMP, Guanine Nucleotide Exchange Factors, MESH: Animals, Neoplasm Metastasis, 0303 health sciences, MESH: Chemokine CXCL12/pharmacology, Chemotaxis, Cell migration, MESH: Metformin/pharmacology, Metformin, 3. Good health, Actin Cytoskeleton, medicine.anatomical_structure, MESH: Chemotaxis/drug effects, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Oncology, 030220 oncology & carcinogenesis, MESH: Cell Movement/drug effects, MESH: rac1 GTP-Binding Protein/antagonists & inhibitors, medicine.drug, MESH: Xenograft Model Antitumor Assays, MESH: Cell Line, Tumor, MESH: Prostatic Neoplasms/enzymology, Mice, Nude, RAC1, MESH: Prostatic Neoplasms/pathology, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Biology, 03 medical and health sciences, DU145, Cell Line, Tumor, medicine, MESH: Cyclic AMP/metabolism, MESH: Mice, Nude, Animals, Humans, Neoplasm Invasiveness, 030304 developmental biology, Cell Proliferation, MESH: Humans, Cancer, Prostatic Neoplasms, MESH: Guanine Nucleotide Exchange Factors/metabolism, MESH: Neoplasm Invasiveness, medicine.disease, Xenograft Model Antitumor Assays, MESH: Neoplasm Metastasis, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Chemokine CXCL12, MESH: Male, Cancer research

  10. 10

    المصدر: Immunology, Vol. 111, No 4 (2004) pp. 416-21